Which dialysis modality is most effective in treating acute…
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Dialysis AKI Abridged (22 April 2020) v1.6 CAVFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Dialysis AKI Abridged (22 April 2020) v1.6 CAVFor any questions or information, please email: covidrapidreviewteam@gmail.com.
NPIR Abridged 20Apr2020 LFD JTFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Ibuprofen abridged LFD 21Apr2020 SVA IGC LFD (1)For any questions or information, please email: covidrapidreviewteam@gmail.com.
Dialysis Method Abridged 17April2020 Version1 PMC JAC JJB JAM LPVFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Camostat mesilate Abridged 8 May 2020 Version 2 JDMFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Etoposide ABRIDGED 09Apr2020 ND_V4_04172020_1532For any questions or information, please email: covidrapidreviewteam@gmail.com.
Asymptomatic_transmission_Abridged_26June2020_version4_AFM,KLRFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Hemoperfusion Abridged 17Apr2020For any questions or information, please email: covidrapidreviewteam@gmail.com.
Sedation abridged 15Apr2020 V1 CTLFor any questions or information, please email: covidrapidreviewteam@gmail.com.
RAS antagonists abridged 1MAY2020 V 2.0Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.